The EPO published European Patent Application EP4172324A1 for Theolytics Ltd., covering methods and systems for generating diverse viral libraries. The application falls under IPC classification C12N 7/02 and designates 31 European states including AT, BE, DE, ES, FR, GB, IT, NL, and others. This represents a formal patent publication rather than a grant of rights.

Pharmaceutical companies and biotechnology researchers working with viral vectors or viral-based therapeutics should review this patent to assess potential freedom-to-operate implications or licensing opportunities. Companies developing viral libraries or related screening technologies in designated EU territories should conduct patent clearance analyses. The patent publication stage means potential oppositions may be filed within nine months of publication.